Sign in
Home
Media News
About Us
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
American Biotech News
Home
Media News
About Us
Contact Us
Home
Tags
Biogen
Tag: Biogen
Biotechnology
One-Time Treatment: Base Editing Shows Promise vs. SMA
-
March 30, 2023
Biotechnology
StockWatch: FDA Panel Enables Accelerated OK for Biogen ALS Drug
-
March 24, 2023
Biotechnology
The Unbearable Cost of Drug Development: Deloitte Report Shows 15% Jump...
-
February 28, 2023
Biotechnology
StockWatch: Biogen’s New CEO Takes Slow Approach to New Cost Cuts
-
February 17, 2023
Biotechnology
StockWatch: Analysts Sour on Roche after Alzheimer’s Clinical Failure
-
November 17, 2022
Biotechnology
StockWatch: Biogen Stays Flat Despite Positive 128-Week Aduhelm Data
-
March 18, 2022
Biotechnology
FDA Seeks Review of Staff-Biogen Talks Leading to Alzheimer’s Drug Approval
-
July 12, 2021
Biotechnology
Biogen Alzheimer’s Drug Wins Historic Approval, but FDA Requires New Trial
-
June 7, 2021
Biotechnology
Sangamo CEO Ponders Pipeline, Reflects on Phase III ‘Proud Moment’
-
February 1, 2021
Biotechnology
Biogen Shares Surge after Reversal on Alzheimer’s Candidate Aducanumab
-
October 22, 2019
Edit with Live CSS